Management of Osteoarthritis in Spinal and Joint Systems

Osteoarthritis is a multifactorial degenerative disorder characterised by progressive loss of articular cartilage, subchondral bone remodelling and synovial inflammation. In spinal and peripheral joints, disease management aims to alleviate pain, preserve joint function and delay structural deterioration. Conservative interventions include patient education, weight management, physiotherapy and pharmacotherapy such as non-steroidal anti-inflammatory drugs to control pain and stiffness. Mechanistic understanding of subchondral bone changes has led to interest in bone-active agents, notably parathyroid hormone analogues and calcitonin, which may exert chondroprotective and anti-resorptive effects. Minimally invasive procedures, including intra-articular injections of hyaluronic acid or corticosteroids, provide temporary symptom relief. Surgical strategies range from joint decompression and fusion in the spine to osteotomy and arthroplasty in advanced peripheral joint disease. Emerging biological therapies and gene-targeted approaches hold promise for disease modification by targeting molecular pathways involved in cartilage repair and subchondral bone turnover. Integration of imaging biomarkers and patient-reported outcome measures informs personalised treatment algorithms, underscoring the global imperative to develop safe, effective and accessible therapies for this prevalent chronic condition.

Research from Nature Portfolio

Recent studies have investigated the role of calcitonin gene-related peptides in post-traumatic osteoarthritis, revealing that alternative splicing of the CALCA gene yields distinct peptide transcripts with opposing effects on cartilage integrity and osteophyte formation. Experimental deletion of specific transcripts in murine models demonstrated increased cartilage degeneration and subchondral bone loss, identifying CALCA-encoded peptides as novel therapeutic targets. In a foundational preclinical investigation, systemic administration of calcitonin attenuated cartilage degradation and reduced nociceptive behaviour in an experimental rat model. This work highlighted the upregulation of transforming growth factor-β in chondrocytes as a key mechanism by which calcitonin modulates cartilage metabolism and synovial inflammation, suggesting potential utility of calcitonin or its analogues as disease-modifying agents in joint osteoarthritis.

Management of Osteoarthritis in Spinal and Joint Systems publication trend

The graph below shows the total number of articles in management of osteoarthritis in spinal and joint systems across all publications each year (not limited to Nature Index journals).

Technical terms

Articular cartilage: The smooth, load-bearing tissue covering the ends of bones within synovial joints, crucial for frictionless movement.

Subchondral bone: The bone layer directly beneath the articular cartilage, whose remodelling contributes to osteoarthritis progression.

Chondrocyte: A specialised cell responsible for producing and maintaining the extracellular matrix of articular cartilage.

Osteophyte: A bony outgrowth that forms at joint margins in response to mechanical stress and cartilage degeneration.

Parathyroid hormone (PTH): A regulator of calcium homeostasis that, when administered intermittently, exerts anabolic effects on bone and cartilage.

Calcitonin: A peptide hormone that inhibits bone resorption and modulates chondrocyte metabolism, with potential chondroprotective actions.

References

1. Transcript-dependent effects of the CALCA gene on the progression of post-traumatic osteoarthritis in mice. Communications Biology (2024).
2. Calcitonin attenuates cartilage degeneration and nociception in an experimental rat model of osteoarthritis: role of TGF-β in chondrocytes. Scientific Reports (2016).
3. Potential effects of teriparatide (PTH (1–34)) on osteoarthritis: a systematic review. Arthritis Research & Therapy (2023).
4. Teriparatide ameliorates articular cartilage degradation and aberrant subchondral bone remodeling in DMM mice. Journal of Orthopaedic Translation (2022).